TP53 and ovarian carcinoma: In contrast with a previous study showing that patients with hotspot TP53 R273 mutant ovarian cancer had significantly longer median OS than those with other hotspot TP53 mutations [29], our study revealed that a hotspot TP53 R273 mutation was associated with poor survival in patients with metastatic colorectal cancer.